Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society
-
* Corresponding author: Marilia B Gomes mariliabgomes@uol.com.br
1 Medicine School of Universidade São Paulo, InCor - HCFMUSP Diabetes Core. Sao Paulo, Brazil
2 Paulista Medicine School at Universidade Federal São Paulo - UNIFESP, Sao Paulo, Brazil
3 Integrated Center of Cardiovascular Hypertension and Metabology at the Kidney and Hypertension Hospital at Universidade Federal de São Paulo, São Paulo, Brazil
4 Diabetes Center of Hospital Alemão Oswaldo Cruz, in Sao Paulo, Brazil
5 University of Sao Paulo Medical School. Sao Paulo, Brazil
6 Medical School at Universidade Federal Rio Grande do Sul and Hospital Clínicas in Porto Alegre, Porto Alegre, Brazil
7 Medicine School of Universidade Federal Rio de Janeiro and Division of Nutrology and Diabetes Service at UFRJ Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
8 Medicine School of State University of Rio de Janeiro, Rio de Janeiro, Brazil
9 InCor Lipid Clinical InCor - HCFMUSP, Sao Paulo, Brazil
10 Universidade Federal da Bahia - UFBA, Salvador, Brazil
11 Diabetes Core. InCor- HCFMUSP and Diabetes Center of Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil
12 Internal Medicine Service at Beneficencia Portuguesa, Sao Paulo, Brazil
Diabetology & Metabolic Syndrome 2010, 2:35 doi:10.1186/1758-5996-2-35
Published: 8 June 2010Abstract
The Brazilian Diabetes Society is starting an innovative project of quantitative assessment of medical arguments of and implementing a new way of elaborating SBD Position Statements. The final aim of this particular project is to propose a new Brazilian algorithm for the treatment of type 2 diabetes, based on the opinions of endocrinologists surveyed from a poll conducted on the Brazilian Diabetes Society website regarding the latest algorithm proposed by American Diabetes Association /European Association for the Study of Diabetes, published in January 2009.
An additional source used, as a basis for the new algorithm, was to assess the acceptability of controversial arguments published in international literature, through a panel of renowned Brazilian specialists. Thirty controversial arguments in diabetes have been selected with their respective references, where each argument was assessed and scored according to its acceptability level and personal conviction of each member of the evaluation panel.
This methodology was adapted using a similar approach to the one adopted in the recent position statement by the American College of Cardiology on coronary revascularization, of which not only cardiologists took part, but also specialists of other related areas.